{"id":"clm_E814D4173C5E","entity":"vertex-pharmaceuticals","predicate":"operating_income","value":"113,820,000 United States dollar","value_json":{"fy":2011,"accn":"0001047469-12-001298","form":"10-K","filed":"2012-02-22","concept":"us-gaap:OperatingIncomeLoss"},"valid_from":"2011-12-31","valid_to":"2012-12-31","published":"2012-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Vertex Pharmaceuticals operating income: 113,820,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_E814D4173C5E, https://asof.is/claim/clm_E814D4173C5E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm.","url":"https://asof.is/claim/clm_E814D4173C5E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_4F9C4EE9CB90","supersedes":["clm_9472043EC2FF"],"first_seen_at":"2026-11-08T17:02:19.315232+00:00","updated_at":"2026-11-08T17:02:31.267986+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2011","published_at":"2012-02-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-22"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}